Avid Bioservices Inc (CDMO)

[biopharm]

RRdog... I think its a tough subject re: ATM vs. loan vs. selling part of the IP vs. (what you mentioned) sell/lease Avid with option to buyback. That Avid sell/lease back is interesting and if they could work it out where its a trusted 3rd party it "could" work but I doubt it only because of all the opposition against Peregrine. I wouldn't want "any" 3rd party knowing the production "real time" current production going on or Avid customers or be in any position to have any insight into Peregrines plans than needed. An example would be even the "transfer agent" that needed to be changed.

I may be overly cautious and skeptic of anyone dealing with Peregrine... but thats what Fargo like trials makes one (at least me) think.

Back to the ATM dilution: thats a argument that can be debated on both sides and hope a partnership soon will place all the dilution concerns to sleep. I just can't wait for the day that CEO Steve King tells us once again that they are moving away from the ATM and no longer need to use it.

Another side of the issue is where are the ATM shares going? ... which may be best for shareholders to allow that shift in ownership if indeed some "family" or group or entity had a high ownership of shares that would place the poison pill at risk in the future.

I hope you do post more often, even if it does mean you disagree because you can give another side of the argument and may change peoples way of thinking. On most all cases I think you are absolutely correct... just I think Peregrine feels they have something in "PS targeting" that they feel is worth much more than many think and many things are happening with Peregrine that I see in no other biotech stock from 1) strong opposition 2) no early partnering in phase I 3) Fargo like trials 4) The passing of Dr. Thorpe 5) transfer agent change 6) ...all this while we have complete silence from the company and 5) Federal Authorities involved at how many levels .... ?

My gut feeling tells me that they do have what every Big Pharma wants.